Individualized SABR for Lung Tumors Yields Low Recurrence Rates

(MedPage Today) -- Individualizing stereotactic ablative radiotherapy (SABR) dose and fractionation according to tumor size, location, and histological characteristics was associated with "excellent" local control and low rates of severe toxic...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news